ArticlePediatric research2026
Burden, trends and economic impact of infant mortality from congenital heart diseases in India, 1990-2021.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongenital heart defects (CHDs) affect approximately 9 per 1000 live births in India, generating an estimated 180,000 to 200,000 new cases annually. Despite this burden, contemporary national data on CHD related mortality trends remain limited.
methodsUsing the Global Burden of Disease 2021 dataset, we analyzed trends in CHD related infant (CHD-IM) and neonatal mortality (CHD-NM) in India from 1990 to 2021, benchmarked against global trends, and estimated associated economic losses using human capital and value of statistical life (VSL) frameworks.
resultsBetween 1990 and 2021, India accounted for approximately 1.5 million of 8.6 million global CHD related infant deaths, roughly 18% of the global burden. India's CHD-NM declined at an annual percent change of -1.5%, significantly slower than the global rate of -2.2%. Segmental analysis revealed stagnation during 2003 to 2013, followed by a nearly threefold acceleration in 2019 to 2021. Substantial subnational inequities in mortality reduction were also identified. The estimated economic loss from CHD related infant deaths in India reached USD 11.7 billion in 2021.
conclusionsThese findings highlight persistent gaps in early detection, equitable cardiac care access, and neonatal infrastructure as critical targets for sustaining and accelerating mortality reduction in India. IMPACT: Critical congenital heart disease (CHD) continues to be an important contributor to child mortality in India. Persistent gaps in population-level mortality data obscure the true magnitude of the burden, undermining targeted policy responses. Declines in neonatal and infant mortality attributable to CHD have lagged behind global trends. CHD-related infant mortality in India was associated with an estimated $9-12 billion in lost economic value. Comprehensive system-level reforms are needed to expand pediatric cardiology training, improve service delivery in public healthcare facilities, and strengthen national surveillance and longitudinal follow-up.
Identifiers
42728311What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.